Kaleido Biosciences, Inc

Company Description

Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health.

Company Overview

NameKaleido Biosciences, Inc
SectorBiotechnology

IPO Data

Date28.02.2019
Price$ 20
Offer Share4,761,905
Deal Size$ 114,999,990
Company SymbolKLDO
Stock MarketNASDAQ (NASDAQ)
Popular Investor - EN
E-NEWSLETTER SUBSCRIPTION
Subscribe to our e-mail list to be notified of updates and recent announcements on our website.
FOLLOW US
Don't forget to follow us on social media